Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) AI workshop – Smart regulation in a rapidly evolving world
This joint HMA/EMA workshop on AI follows on from the 2021 workshop where stakeholders provided their views on the priority AI-related topics. The Medicines Regulatory Network (EMRN) has worked on delivering on these priorities as well as monitoring the rapid evolution of AI tools and techniques and the developing legislative environment.
The objectives of this workshop are to:
- engage stakeholders with keynote speakers on AI developments in technology, policy and potential applications in medicines regulation,
- inform on the HMA/EMA activities to deliver the stakeholder’s priorities on AI,
- discuss with stakeholders and experts on the draft AI reflection paper.
The event will be broadcast live.
A video recording will be available after the event.